# Clinical Study to Investigate the Efficacy and the Safety of DA-9501 in Sedation During the Surgery or Medical Procedure Without Intubation

> **NCT01438931** · PHASE3 · COMPLETED · sponsor: **Hospira, now a wholly owned subsidiary of Pfizer** · enrollment: 162 (actual)

## Conditions studied

- Sedation

## Interventions

- **DRUG:** DA-9501
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01438931
- **Lead sponsor:** Hospira, now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-02
- **Final completion:** 2012-03
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2015-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01438931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01438931, "Clinical Study to Investigate the Efficacy and the Safety of DA-9501 in Sedation During the Surgery or Medical Procedure Without Intubation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01438931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*